Recently serious concern was expressed by some senior doctors and doctors’ associations regarding the shortage of clofazimine, a drug urgently needed in the treatment of leprosy. The shortage is confined to private hospitals but nevertheless is affecting the treatment of many leprosy patients who need multi-drug combination treatment and the absence of one key drug adversely affects the overall treatment.[Read More...]
Source